Additionally, induction of PTF1a in PDAC influenced cancer‐associated properties, leading to decreases in cell proliferation, CSC numbers, and repression of ABC efflux transporters resulting in heightened sensitivity to gemcitabine. Here, PTF1A is linked to cancer.